CardioInfo

    • Home
    • News
    • Dai congressi
    • Dalle riviste
    • Interviste
    • Newsletter
    • Speciale COVID-19
    •  
    •  
    •  

    Annunciati i Late-Breaking Clinical Trials di ACC.21

    • in In primo piano · News -
    • 09/03/2021

    Sono stati annunciati i Late-Breaking Clinical Trials di ACC.21, il meeting annuale dell’American College of Cardiology in programma dal 15 al 17 maggio in formato virtuale.

    ACC.21

    Late-Breaking Clinical Trials I

    American College of Cardiology / Journal of the American College of Cardiology
    Sabato 15 maggio | 15:00 – 16:00:

    • PARADISE-MI: Prospective Arni Versus Ace Inhibitor Trial To Determine Superiority In Reducing Heart Failure Events After Myocardial Infarction
    • ADAPTABLE Study: Aspirin Dosing: A Patient-centric Trial Assessing Benefits And Long-term Effectiveness Trial
    • LAAOS III: The Left Atrial Appendage Occlusion Study III
    Late-Breaking Clinical Trials II

    American College of Cardiology / Journal of the American Medical Association
    Domenica 16 maggio | 14:00 – 15:30:

    • Effects Of Dapagliflozin On Prevention Of Major Clinical Events And Recovery In Patients With Respiratory Failure Due To COVID-19 – Main Results From The DARE-19 Randomized Trial
    • VOYAGER PAD Trial: Reductions In Total Ischemic Events With Rivaroxaban In Patients With Symptomatic Pad After Revascularization
    • STAMPEDE Trial: Surgical Versus Medical Treatment Of Type 2 Diabetes: 10-year Results of the Stampede Randomized Clinical Trial
    • REHAB-HF Trial: A Novel Physical Rehabilitation Intervention For Older Patients With Acute Decompensated Heart Failure
    • Relationship Between Omega-3 Fatty Acid Levels And Major Adverse Cardiovascular Outcomes In Patients With High Cardiovascular Risk
    • PRADA Trial: Prevention Of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: Long-term Follow-up Of A 2 X 2 Factorial, Randomized, Placebo-controlled, Double-blind Clinical Trial Of Candesartan And Metoprolol
    Late-Breaking Clinical Trials III

    American College of Cardiology / New England Journal of Medicine
    Domenica 16 maggio | 16:45 – 18:15:

    • The FLOWER-MI Randomized Trial: Fractional Flow Reserve-guided Versus Angio-guided Multivessel Revascularization In ST-Elevation Myocardial Infarction Patients
    • A Prospective, Multicenter, Randomized, Open-label Trial To Compare Efficacy And Safety Of Clopidogrel Versus Ticagrelor In Stabilized Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention
    • Host Exam Randomized Controlled Trial: Aspirin Vs. Clopidogrel During Chronic Maintenance Monotherapy After Percutaneous Coronary Intervention
    • Late Outcomes Of A 1-hour High Sensitivity Troponin T Protocol In Suspected Acute Coronary Syndromes: A Randomized Clinical Trial
    • Randomized Sham-controlled RADIANCE-HTN TRIO Trial: Endovascular Ultrasound Renal Denervation To Treat Hypertension Resistant To A Fixed Dose Triple Medication Pill
    Late-Breaking Clinical Trials IV

    Lunedì 17 maggio | 14:00 – 15:30

    • Benefits Of Sodium Glucose Co-transporter-1/2 Inhibition With Sotagliflozin Across The Full Spectrum Of Ejection Fraction, Including Heart Failure With Preserved Ejection Fraction
    • Primary Results of the Connect-hf Randomized Clinical Trial: Care Optimization Through Patient And Hospital Engagement Clinical Trial For Heart Failure
    • Results of the LIFE Trial: Sacubitril/Valsartan (LCZ696) In Patients With Advanced Heart Failure And Reduced Ejection Fraction
    • Pirfenidone In Heart Failure With Preserved Ejection Fraction
    • Secondary Analysis From GALACTIC-HF: Impact Of Ejection Fraction On The Therapeutic Effect Of Omecamtiv Mecarbil In Patients With Heart Failure And Reduced Ejection Fraction
    Late-Breaking Clinical Trials V

    Lunedì 17 maggio | 16:45 – 18:15

    • Therapeutic Hypothermia Following Out-Of-Hospital Cardiac Arrest: A Randomized Trial Comparing Mild And Moderate Therapeutic Hypothermia
    • Prague OHCA Study: Hyperinvasive Approach In Refractory Out-of-Hospital Cardiac Arrest: An Open-label Randomized Controlled Trial
    • RAFT-AF: A Randomized Ablation-based Atrial Fibrillation Rhythm Control Versus Rate Control Trial In Patients With Heart Failure And High Burden Atrial Fibrillation
    • Acute Alcohol Consumption And Discrete Atrial Fibrillation Events
    • Finerenone And New Onset Of Atrial Fibrillation Or Flutter In Patients With Chronic Kidney Disease And Type 2 Diabetes

     

    Potrebbe interessarti

    • ESC 2020
      ESC 2020, ecco la lista dei late-breaking trials

      Prime informazioni sul meeting virtuale dell'European Society of Cardiology. Gli studi saranno presentati alle 14:00…

    • ACC.20
      Speciale ACC.20

    • ACC.17: troponina T post-chirurgica, marker del danno cardiaco

      I danni cardiaci non identificati causano il 25% dei decessi nei 30 giorni successivi agli…

    • cardiologi twitter
      Un webinar sullo scompenso cardiaco

      “Guidelines, clinical wisdom and common sense” sarà trasmesso in streaming il 16 novembre.

    Tags: ACC.21American College of CardiologyJournal of the American College of CardiologyJournal of the American Medical AssociationLate-Breaking Clinical Trials

  • @Cardioinfo_it

    Twitter
    Arturo Cesaro
    Arturo Cesaro
    @arturocesaro

    How should I treat? @doctorteuz @paolocalabro1 @BettiMoscarella @FeliceGragnano @MondaEmanuele @Cardioinfo_it twitter.com/PCRonlin…

    Risposta Retweet Preferiti
    15:55 · 21/04/2021 ·
    Ritwittato da Cardioinfo
    Twitter
    Cardioinfo
    Cardioinfo
    @Cardioinfo_it

    I risultati di una revisione sistematica e metanalisi sul confronto tra le due strategie, pubblicata su @TheLancet. @MattiaGalli10 @DFCapodanno @DDamario @ItaloPorto2 cardioinfo.it/news/t…

    Risposta Retweet Preferiti
    14:21 · 21/04/2021
    Twitter
    Cardioinfo
    Cardioinfo
    @Cardioinfo_it

    “Un antico sogno dei cardiologi”, come li ha definiti Luigi Tavazzi. cardioinfo.it/news/s…

    Risposta Retweet Preferiti
    12:19 · 21/04/2021
    Twitter
    European Society of Cardiology Journals
    European Society of Cardiology Journals
    @ESC_Journals

    Disrupted sleep is linked to increased risk of death, particularly in women academic.oup.com/eur… #EHJ #ESCYoung #cardiotwitter #CVD @ehj_ed @rladeiraslopes @escardio pic.twitter.com/BcI2…

    Risposta Retweet Preferiti
    07:16 · 21/04/2021 ·
    Ritwittato da Cardioinfo
    Twitter
    World Heart Federation
    World Heart Federation
    @worldheartfed

    Prof Roberto Ferrari: "Fear of #COVID19 infection reduces the number of people hospitalized for angina. As doctors, we need to emphasise to our patients the “safety” of our hospitals and the need to continue (and/or improve) preventive and antianginal therapy." #ActNowOnAngina

    Risposta Retweet Preferiti
    14:42 · 20/04/2021 ·
    Ritwittato da Cardioinfo
    Segui @Cardioinfo_it
  • CARDIOINFO@ESC

    • ESC 2020
    • ESC 2019
    • ESC 2018
    • ESC 2017
    • ESC 2016
    • ESC 2015
  • Iscriviti alla newsletter

    Quando invii il modulo, controlla la tua inbox per confermare l'iscrizione

    • Redazione

      Editor in Chief: Luciano De Fiore
      Redazione: David Frati, Fabio Ambrosino, Paola Luciolli, Livia Costa, Maria Nardoianni
    • Privacy Policy Cookie Policy
    • Dalle riviste

      • I cinquant’anni del Giornale Italiano di Cardiologia 01/02/2021
      • COVID-19: quali implicazioni per la cardiologia? 12/03/2020
      • Accesso e sostenibilità degli inibitori di PCSK9 15/03/2019
      • Inibitori di PCSK9 per il trattamento dell’ipercolesterolemia 15/03/2019
      • Twitter, uno strumento in più a disposizione dei cardiologi 22/01/2019
    • Interviste

      • Riparazione percutanea della valvola mitralica: i vantaggi della tecnica “Pascal” 09/04/2021
      • I 50 anni del GIC | Progressi nel trattamento dell’ipertensione arteriosa 31/03/2021
      • L'”effetto donna” nella Malattia di Anderson-Fabry 18/03/2021
      • Ablazione con elettroporazione, una nuova frontiera per la fibrillazione atriale 11/03/2021
      • I 50 anni del GIC | Progressi nel trattamento dell’infarto miocardico acuto 08/03/2021
      • I 50 anni del GIC | Progressi nell’imaging cardiaco 08/02/2021
    • Contatti

        * Campi obbligatori

      Una pubblicazione de Il Pensiero Scientifico Editore e Think2it | Tutti i diritti riservati
      Registrazione al Tribunale di Roma n. 285/2015